Evicenter
Nucala (mepolizumab) in Severe eosinophilic asthma
Manufacturer
GlaxoSmithKline
Prescribing information
Nucala (opens in a new tab)
Questions
38
Last updated

All questions

Real-world evidence: Nucala (mepolizumab) in severe eosinophilic asthma

4 questions · 3 sources

Real-world evidence

Did Nucala reduce asthma exacerbations in real-world use (REALITI-A)?

How many patients stopped Nucala in the REALITI-A real-world study?

Did Nucala reduce asthma hospitalizations in the REALITI-A real-world study?

How many OCS-dependent REALITI-A patients stopped oral steroids on Nucala?

Note: The page shows the percentage in a graphic that the capture did not record as text; the quoted count is 95 of 168 patients.